Skip to main content

Fiscal Wizard · Single-issue tearsheet

VCEL / Jun 20, 2026 Run #7271

VCEL

Vericel Corporation

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. Vericel Corporation was formerly known as Aastrom Biosciences, Inc. and changed its name to Vericel Corporation in November 2014. The company was incorporated in 1989 and is headquartered in Burlington, Massachusetts.

Composite verdict

B 74.2 / 100
Bullish setup · Trend Following 15 drivers · 4 gates blocking
  • Sushi Roll
  • Rate of Change
  • ADX DI Cross
Consider long call target Δ ~0.60 · ~35 DTE Bullish setup, Grade B → ITM call target

Industry rank 24th of 598 in Biotechnology

rescore-sweep
Technical synthesisRegime: range
Bull 100%Evidence: High · 18 signals0% Bear
Momentum Bullish 99Mean-reversion Neutral 50

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes fromMargin of safety -82%
Asset value $6.94Earnings power value $4.24Price $40.10

Priced above its no-growth earnings power value ($4.24/share) — you're paying for growth and franchise expansion, not just current earnings.

Fundamentals Mixed

48.4 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
EPS Growth (YoY) 100
Margin of Safety 0
Asset Turnover 100
OCF to Net Income 0
Return on Assets 83
Earnings Yield 0

Technicals Bullish

100.0 / 100

Bullish setup leads (Sushi Roll, Rate of Change, ADX DI Cross); bears gated by guards. · 43 signals shown.

Strongest
Weakest
Sushi Roll 95
Rate of Change 94
Parabolic SAR Flip 85

Risk Gates

4 blocking 4 caution

4 guards active, 24 signals gated.

ADX Trend Weakness Blocking

Weak trend strength blocks trend-following signals in either direction.

MA Crossover Blocking

Blocks counter-regime signals only when the MA crossover agrees with the long-term regime.

Realized Volatility Regime Blocking

High-vol regime mutes mean-reversion signals; low-vol regime mutes breakout signals.

Regime Filter Blocking

Blocks signals that oppose the long-term moving-average regime.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for VCEL.